Dr. Harris is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
102 Endicott St
Danvers, MA 01923Phone+1 978-882-6060
Summary
- Dr. Katherine Harris is an oncologist located in Boston, MA, specializing in breast cancer. She completed her fellowship in Hematology and Medical Oncology and her residency in Internal Medicine at the University of California, San Francisco, following her graduation from Pennsylvania State University College of Medicine. Her published research includes studies on breast cancer diagnostics and treatment, with several works cited multiple times in other publications. She has been recognized with awards such as the Patient-Centered Specialty Practice Recognition from the National Committee for Quality Assurance and Meaningful Use Stage 1 Certification from the Centers for Medicare & Medicaid Services.
Education & Training
- University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1997 - 2000
- University of California (San Francisco)Residency, Internal Medicine, 1994 - 1997
- Pennsylvania State University College of MedicineClass of 1994
Certifications & Licensure
- MA State Medical License 2016 - 2025
- PA State Medical License 2002 - 2018
- CA State Medical License 1996 - 2001
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Patient-Centered Specialty Practice Recognition Program National Committee for Quality Assurance, 2014-2017
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- 10 citationsDiscovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3Kα Inhibitor That Decouples Antitumor Activity from Hyperinsulinemia.Andreas Varkaris, Ermira Pazolli, Hakan Gunaydin, Qi Wang, Levi Pierce
Cancer Discovery. 2024-02-08 - 5 citationsAxillary Ultrasound Evaluation in Breast Cancer Patients: A Multidisciplinary Viewpoint and Middle Ground.Mansi Saksena, Rachel Jimenez, Suzanne Coopey, Katherine Harris
Journal of Breast Imaging. 2021-11-16 - 4 citationsBaseline Screening MRI Uptake and Findings in Women with ≥ 20% Lifetime Risk of Breast Cancer.Alison Laws, Therese M. Mulvey, Nicole Jalbert, Sarah Dalton, Olga Kantor
Annals of Surgical Oncology. 2020-07-18
Press Mentions
- Mgh Cancer Center DanversMarch 16th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: